These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. ERG monitoring of retinal function during systemic chemotherapy for retinoblastoma. Brodie SE; Paulus YM; Patel M; Gobin YP; Dunkel IJ; Marr BP; Abramson DH Br J Ophthalmol; 2012 Jun; 96(6):877-80. PubMed ID: 22426950 [TBL] [Abstract][Full Text] [Related]
5. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma. Schaiquevich P; Ceciliano A; Millan N; Taich P; Villasante F; Fandino AC; Dominguez J; Chantada GL Pediatr Blood Cancer; 2013 May; 60(5):766-70. PubMed ID: 23024125 [TBL] [Abstract][Full Text] [Related]
6. Total retinal detachments due to retinoblastoma: Outcomes following intra-arterial chemotherapy/ophthalmic artery chemosurgery. Rowlands MA; Mondesire-Crump I; Levin A; Mauguen A; Francis JH; Dunkel IJ; Brodie SE; Gobin YP; Abramson DH PLoS One; 2018; 13(4):e0195395. PubMed ID: 29698399 [TBL] [Abstract][Full Text] [Related]
7. Intra-arterial chemotherapy as primary or secondary treatment for infants diagnosed with advanced retinoblastoma before 3 months of age. Chen Q; Zhang B; Dong Y; Mo X; Zhang L; Xia J; Zhang J; Zhang S BMC Cancer; 2019 Jul; 19(1):693. PubMed ID: 31307410 [TBL] [Abstract][Full Text] [Related]
8. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma. Berry JL; Bechtold M; Shah S; Zolfaghari E; Reid M; Jubran R; Kim JW Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537 [TBL] [Abstract][Full Text] [Related]
9. Intra-Arterial Chemotherapy as Primary Therapy for Retinoblastoma in Infants Less than 3 Months of Age: A Series of 10 Case-Studies. Chen M; Zhao J; Xia J; Liu Z; Jiang H; Shen G; Li H; Jiang Y; Zhang J PLoS One; 2016; 11(8):e0160873. PubMed ID: 27504917 [TBL] [Abstract][Full Text] [Related]
10. Primary intravenous chemotherapy for group D retinoblastoma: a 13-year retrospective analysis. Fabian ID; Stacey AW; Johnson KP; Onadim Z; Chowdhury T; Duncan C; Reddy MA; Sagoo MS Br J Ophthalmol; 2017 Jan; 101(1):82-88. PubMed ID: 27965263 [TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of primarily treated group D retinoblastoma. Kiratli H; Koç İ; Inam O; Varan A; Akyüz C Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2225-2231. PubMed ID: 29961117 [TBL] [Abstract][Full Text] [Related]
12. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma. Shields CL; Manjandavida FP; Lally SE; Pieretti G; Arepalli SA; Caywood EH; Jabbour P; Shields JA Ophthalmology; 2014 Jul; 121(7):1453-60. PubMed ID: 24656794 [TBL] [Abstract][Full Text] [Related]
13. Evaluating primary intra-arterial chemotherapy versus intravenous plus intra-arterial chemotherapy for advanced intraocular retinoblastoma. Chen Q; Zhang B; Dong Y; Mo X; Zhang L; Xia J; Zhang J; Zhang S Cancer Chemother Pharmacol; 2020 Apr; 85(4):723-730. PubMed ID: 32123960 [TBL] [Abstract][Full Text] [Related]
14. A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy. Lambert MP; Shields C; Meadows AT Pediatr Blood Cancer; 2008 Feb; 50(2):223-6. PubMed ID: 17278120 [TBL] [Abstract][Full Text] [Related]
15. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy. Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423 [TBL] [Abstract][Full Text] [Related]
16. Secondary and tertiary intra-arterial chemotherapy for massive persistent or recurrent subretinal retinoblastoma seeds following previous chemotherapy exposure: long-term tumor control and globe salvage in 30 eyes. Say EA; Iyer PG; Hasanreisoglu M; Lally SE; Jabbour P; Shields JA; Shields CL J AAPOS; 2016 Aug; 20(4):337-42. PubMed ID: 27328850 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience. Francis JH; Brodie SE; Marr B; Zabor EC; Mondesire-Crump I; Abramson DH Ophthalmology; 2017 Apr; 124(4):488-495. PubMed ID: 28089679 [TBL] [Abstract][Full Text] [Related]
18. Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma. Brodie SE; Pierre Gobin Y; Dunkel IJ; Kim JW; Abramson DH Doc Ophthalmol; 2009 Aug; 119(1):13-22. PubMed ID: 19169884 [TBL] [Abstract][Full Text] [Related]